These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 14754692)

  • 1. Postmenopausal hormone therapy and risk of developing urinary incontinence.
    Grodstein F; Lifford K; Resnick NM; Curhan GC
    Obstet Gynecol; 2004 Feb; 103(2):254-60. PubMed ID: 14754692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes mellitus and risk of developing urinary incontinence.
    Lifford KL; Curhan GC; Hu FB; Barbieri RL; Grodstein F
    J Am Geriatr Soc; 2005 Nov; 53(11):1851-7. PubMed ID: 16274364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F; Manson JE; Stampfer MJ
    J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of urinary incontinence in older women: incidence, progression, and remission.
    Lifford KL; Townsend MK; Curhan GC; Resnick NM; Grodstein F
    J Am Geriatr Soc; 2008 Jul; 56(7):1191-8. PubMed ID: 18492035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of urinary incontinence in a prospective cohort of postmenopausal women.
    Jackson SL; Scholes D; Boyko EJ; Abraham L; Fihn SD
    Obstet Gynecol; 2006 Oct; 108(4):855-62. PubMed ID: 17012446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hormone use and cholecystectomy in a large prospective study.
    Grodstein F; Colditz GA; Stampfer MJ
    Obstet Gynecol; 1994 Jan; 83(1):5-11. PubMed ID: 8272307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of raloxifene on urinary incontinence: a randomized controlled trial.
    Waetjen LE; Brown JS; Modelska K; Blackwell T; Vittinghoff E; Cummings SR;
    Obstet Gynecol; 2004 Feb; 103(2):261-6. PubMed ID: 14754693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort.
    Rodriguez C; Spencer Feigelson H; Deka A; Patel AV; Jacobs EJ; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):655-60. PubMed ID: 18349283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II.
    Hildebrand JS; Jacobs EJ; Campbell PT; McCullough ML; Teras LR; Thun MJ; Gapstur SM
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2835-41. PubMed ID: 19843681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy aggravates postmenopausal urinary incontinence.
    Prescrire Int; 2006 Aug; 15(84):137-8. PubMed ID: 16989027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype.
    McCullough ML; Patel AV; Patel R; Rodriguez C; Feigelson HS; Bandera EV; Gansler T; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):73-9. PubMed ID: 18187388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L; Dell'Aniello S; Assouline S; Suissa S
    BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary incontinence and urinary tract infection: temporal relationships in postmenopausal women.
    Moore EE; Jackson SL; Boyko EJ; Scholes D; Fihn SD
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):317-23. PubMed ID: 18238968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unopposed estrogen therapy and the risk of invasive breast cancer.
    Chen WY; Manson JE; Hankinson SE; Rosner B; Holmes MD; Willett WC; Colditz GA
    Arch Intern Med; 2006 May; 166(9):1027-32. PubMed ID: 16682578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living with urinary incontinence: a longitudinal study of older women.
    Byles J; Millar CJ; Sibbritt DW; Chiarelli P
    Age Ageing; 2009 May; 38(3):333-8; discussion 251. PubMed ID: 19258398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.
    Costenbader KH; Feskanich D; Stampfer MJ; Karlson EW
    Arthritis Rheum; 2007 Apr; 56(4):1251-62. PubMed ID: 17393454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors of urinary incontinence in Khon Kaen menopausal women.
    Sakondhavat C; Choosuwan C; Kaewrudee S; Soontrapa S; Louanka K
    J Med Assoc Thai; 2007 Dec; 90(12):2553-8. PubMed ID: 18386703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
    Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
    J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.